Topics

Liquid Biopsy Matches Tissue for NSCLC Treatment Guidance

15:12 EDT 12 Sep 2019 | OncLive

Patients with advanced non–small cell lung cancer and actionable mutations had similar progression-free survival whether treatment guidance came from tissue or circulating tumor (ct)DNA analysis using the Guardant360 assay, a matched retrospective comparison showed.

Original Article: Liquid Biopsy Matches Tissue for NSCLC Treatment Guidance

NEXT ARTICLE

More From BioPortfolio on "Liquid Biopsy Matches Tissue for NSCLC Treatment Guidance"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...